[
    {
        "molecule_name": "antibody",
        "protein_target_name": "myostatin",
        "binding_metric": "IC50",
        "value": "<1",
        "unit": "μM",
        "raw_mentions": "In one embodiment, the antibody, or antigen binding fragment thereof, inhibits proteolytic formation of mature myostatin by tolloid protease with an IC50 of less than 1 μM."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "pro/latent myostatin",
        "binding_metric": "Kd",
        "value": "<10^−6",
        "unit": "M",
        "raw_mentions": "In one embodiment, the antibody, or antigen binding fragment thereof, competes for binding to pro/latent myostatin with an equilibrium dissociation constant, Kd, between the antibody and pro/latent myostatin of less than 10<sup>−6 </sup>M.\nIn one embodiment, the Kd is in a range of 10<sup>−11 </sup>M to 10<sup>−6 </sup>M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "pro/latent myostatin",
        "binding_metric": "Kd",
        "value": "10^−11 to 10^−6",
        "unit": "M",
        "raw_mentions": "In one embodiment, the antibody, or antigen binding fragment thereof, competes for binding to pro/latent myostatin with an equilibrium dissociation constant, Kd, between the antibody and pro/latent myostatin of less than 10<sup>−6 </sup>M.\nIn one embodiment, the Kd is in a range of 10<sup>−11 </sup>M to 10<sup>−6 </sup>M."
    },
    {
        "molecule_name": "anti-pro/latent-myostatin antibodies",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "<10^−6",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some embodiments, an anti-pro/latent-myostatin antibodies, or antigen binding fragments thereof, can bind to pro/latent-myostatin with relatively high affinity, e.g., with a Kd less than 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M or lower.\nFor example, anti-pro/latent-myostatin antibodies, or antigen binding fragments thereof, can bind to pro/latent-myostatin with an affinity between 5 pM and 500 nM, e.g., between 50 pM and 100 nM, e.g., between 500 pM and 50 nM.\nThe invention also includes antibodies or antigen binding fragments that compete with any of the antibodies described herein for binding to pro/latent-myostatin and that have an affinity of 50 nM or lower (e.g., 20 nM or lower, 10 nM or lower, 500 pM or lower, 50 pM or lower, or 5 pM or lower)."
    },
    {
        "molecule_name": "anti-pro/latent-myostatin antibodies",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "<10^−7",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some embodiments, an anti-pro/latent-myostatin antibodies, or antigen binding fragments thereof, can bind to pro/latent-myostatin with relatively high affinity, e.g., with a Kd less than 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M or lower.\nFor example, anti-pro/latent-myostatin antibodies, or antigen binding fragments thereof, can bind to pro/latent-myostatin with an affinity between 5 pM and 500 nM, e.g., between 50 pM and 100 nM, e.g., between 500 pM and 50 nM.\nThe invention also includes antibodies or antigen binding fragments that compete with any of the antibodies described herein for binding to pro/latent-myostatin and that have an affinity of 50 nM or lower (e.g., 20 nM or lower, 10 nM or lower, 500 pM or lower, 50 pM or lower, or 5 pM or lower)."
    },
    {
        "molecule_name": "anti-pro/latent-myostatin antibodies",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "<10^−8",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some embodiments, an anti-pro/latent-myostatin antibodies, or antigen binding fragments thereof, can bind to pro/latent-myostatin with relatively high affinity, e.g., with a Kd less than 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M or lower.\nFor example, anti-pro/latent-myostatin antibodies, or antigen binding fragments thereof, can bind to pro/latent-myostatin with an affinity between 5 pM and 500 nM, e.g., between 50 pM and 100 nM, e.g., between 500 pM and 50 nM.\nThe invention also includes antibodies or antigen binding fragments that compete with any of the antibodies described herein for binding to pro/latent-myostatin and that have an affinity of 50 nM or lower (e.g., 20 nM or lower, 10 nM or lower, 500 pM or lower, 50 pM or lower, or 5 pM or lower)."
    },
    {
        "molecule_name": "anti-pro/latent-myostatin antibodies",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "<10^−9",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some embodiments, an anti-pro/latent-myostatin antibodies, or antigen binding fragments thereof, can bind to pro/latent-myostatin with relatively high affinity, e.g., with a Kd less than 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M or lower.\nFor example, anti-pro/latent-myostatin antibodies, or antigen binding fragments thereof, can bind to pro/latent-myostatin with an affinity between 5 pM and 500 nM, e.g., between 50 pM and 100 nM, e.g., between 500 pM and 50 nM.\nThe invention also includes antibodies or antigen binding fragments that compete with any of the antibodies described herein for binding to pro/latent-myostatin and that have an affinity of 50 nM or lower (e.g., 20 nM or lower, 10 nM or lower, 500 pM or lower, 50 pM or lower, or 5 pM or lower)."
    },
    {
        "molecule_name": "anti-pro/latent-myostatin antibodies",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "<10^−10",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some embodiments, an anti-pro/latent-myostatin antibodies, or antigen binding fragments thereof, can bind to pro/latent-myostatin with relatively high affinity, e.g., with a Kd less than 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M or lower.\nFor example, anti-pro/latent-myostatin antibodies, or antigen binding fragments thereof, can bind to pro/latent-myostatin with an affinity between 5 pM and 500 nM, e.g., between 50 pM and 100 nM, e.g., between 500 pM and 50 nM.\nThe invention also includes antibodies or antigen binding fragments that compete with any of the antibodies described herein for binding to pro/latent-myostatin and that have an affinity of 50 nM or lower (e.g., 20 nM or lower, 10 nM or lower, 500 pM or lower, 50 pM or lower, or 5 pM or lower)."
    },
    {
        "molecule_name": "anti-pro/latent-myostatin antibodies",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "<10^−11",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some embodiments, an anti-pro/latent-myostatin antibodies, or antigen binding fragments thereof, can bind to pro/latent-myostatin with relatively high affinity, e.g., with a Kd less than 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M or lower.\nFor example, anti-pro/latent-myostatin antibodies, or antigen binding fragments thereof, can bind to pro/latent-myostatin with an affinity between 5 pM and 500 nM, e.g., between 50 pM and 100 nM, e.g., between 500 pM and 50 nM.\nThe invention also includes antibodies or antigen binding fragments that compete with any of the antibodies described herein for binding to pro/latent-myostatin and that have an affinity of 50 nM or lower (e.g., 20 nM or lower, 10 nM or lower, 500 pM or lower, 50 pM or lower, or 5 pM or lower)."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−3 to 10−8",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−3 to 10−7",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−3 to 10−6",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−3 to 10−5",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−3 to 10−4",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−4 to 10−8",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−4 to 10−7",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−4 to 10−6",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−4 to 10−5",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−5 to 10−8",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−5 to 10−7",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−5 to 10−6",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−6 to 10−8",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−6 to 10−7",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "sweeping antibody",
        "protein_target_name": "FcRn",
        "binding_metric": "Kd",
        "value": "10−7 to 10−8",
        "unit": "M",
        "raw_mentions": "In some embodiments, the Fe portion of a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−8 </sup>M.\nIn some embodiments, a sweeping antibody binds to FcRn at a pH of 7.4 with a Kd ranging from 10<sup>−3 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−6</sup>M, from 10<sup>−3 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−3 </sup>M to 10<sup>−4 </sup>M, from 10<sup>−4</sup>M to 10<sup>−8 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−4 </sup>M to 10<sup>−5 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−7 </sup>M, from 10<sup>−5 </sup>M to 10<sup>−6 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−8 </sup>M, from 10<sup>−6 </sup>M to 10<sup>−7 </sup>M, or from 10<sup>−7 </sup>M to 10<sup>−8</sup>M."
    },
    {
        "molecule_name": "antibodies, or antigen binding fragments thereof",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "10^−3",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−3 </sup>M, 10<sup>−4 </sup>M, 10<sup>−5 </sup>M, 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M when the pH is between 4.0 and 6.5.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M when the pH is between 7.0 and 7.4.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-Myostatin that is at least 2-fold, at least 10-fold, at least 50-fold, at least 100-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, or at least 10000-fold greater at a pH between 4.0 and 6.5 as compared to a pH between 7.0 and 7.4."
    },
    {
        "molecule_name": "antibodies, or antigen binding fragments thereof",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "10^−4",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−3 </sup>M, 10<sup>−4 </sup>M, 10<sup>−5 </sup>M, 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M when the pH is between 4.0 and 6.5.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M when the pH is between 7.0 and 7.4.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-Myostatin that is at least 2-fold, at least 10-fold, at least 50-fold, at least 100-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, or at least 10000-fold greater at a pH between 4.0 and 6.5 as compared to a pH between 7.0 and 7.4."
    },
    {
        "molecule_name": "antibodies, or antigen binding fragments thereof",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "10^−5",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−3 </sup>M, 10<sup>−4 </sup>M, 10<sup>−5 </sup>M, 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M when the pH is between 4.0 and 6.5.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M when the pH is between 7.0 and 7.4.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-Myostatin that is at least 2-fold, at least 10-fold, at least 50-fold, at least 100-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, or at least 10000-fold greater at a pH between 4.0 and 6.5 as compared to a pH between 7.0 and 7.4."
    },
    {
        "molecule_name": "antibodies, or antigen binding fragments thereof",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "10^−6",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−3 </sup>M, 10<sup>−4 </sup>M, 10<sup>−5 </sup>M, 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M when the pH is between 4.0 and 6.5.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M when the pH is between 7.0 and 7.4.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-Myostatin that is at least 2-fold, at least 10-fold, at least 50-fold, at least 100-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, or at least 10000-fold greater at a pH between 4.0 and 6.5 as compared to a pH between 7.0 and 7.4."
    },
    {
        "molecule_name": "antibodies, or antigen binding fragments thereof",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "10^−7",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−3 </sup>M, 10<sup>−4 </sup>M, 10<sup>−5 </sup>M, 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M when the pH is between 4.0 and 6.5.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M when the pH is between 7.0 and 7.4.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-Myostatin that is at least 2-fold, at least 10-fold, at least 50-fold, at least 100-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, or at least 10000-fold greater at a pH between 4.0 and 6.5 as compared to a pH between 7.0 and 7.4."
    },
    {
        "molecule_name": "antibodies, or antigen binding fragments thereof",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "10^−8",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−3 </sup>M, 10<sup>−4 </sup>M, 10<sup>−5 </sup>M, 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M when the pH is between 4.0 and 6.5.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M when the pH is between 7.0 and 7.4.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-Myostatin that is at least 2-fold, at least 10-fold, at least 50-fold, at least 100-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, or at least 10000-fold greater at a pH between 4.0 and 6.5 as compared to a pH between 7.0 and 7.4."
    },
    {
        "molecule_name": "antibodies, or antigen binding fragments thereof",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "10^−6",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−3 </sup>M, 10<sup>−4 </sup>M, 10<sup>−5 </sup>M, 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M when the pH is between 4.0 and 6.5.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M when the pH is between 7.0 and 7.4.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-Myostatin that is at least 2-fold, at least 10-fold, at least 50-fold, at least 100-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, or at least 10000-fold greater at a pH between 4.0 and 6.5 as compared to a pH between 7.0 and 7.4."
    },
    {
        "molecule_name": "antibodies, or antigen binding fragments thereof",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "10^−7",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−3 </sup>M, 10<sup>−4 </sup>M, 10<sup>−5 </sup>M, 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M when the pH is between 4.0 and 6.5.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M when the pH is between 7.0 and 7.4.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-Myostatin that is at least 2-fold, at least 10-fold, at least 50-fold, at least 100-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, or at least 10000-fold greater at a pH between 4.0 and 6.5 as compared to a pH between 7.0 and 7.4."
    },
    {
        "molecule_name": "antibodies, or antigen binding fragments thereof",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "10^−8",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−3 </sup>M, 10<sup>−4 </sup>M, 10<sup>−5 </sup>M, 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M when the pH is between 4.0 and 6.5.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M when the pH is between 7.0 and 7.4.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-Myostatin that is at least 2-fold, at least 10-fold, at least 50-fold, at least 100-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, or at least 10000-fold greater at a pH between 4.0 and 6.5 as compared to a pH between 7.0 and 7.4."
    },
    {
        "molecule_name": "antibodies, or antigen binding fragments thereof",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "10^−9",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−3 </sup>M, 10<sup>−4 </sup>M, 10<sup>−5 </sup>M, 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M when the pH is between 4.0 and 6.5.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M when the pH is between 7.0 and 7.4.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-Myostatin that is at least 2-fold, at least 10-fold, at least 50-fold, at least 100-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, or at least 10000-fold greater at a pH between 4.0 and 6.5 as compared to a pH between 7.0 and 7.4."
    },
    {
        "molecule_name": "antibodies, or antigen binding fragments thereof",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "10^−10",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−3 </sup>M, 10<sup>−4 </sup>M, 10<sup>−5 </sup>M, 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M when the pH is between 4.0 and 6.5.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M when the pH is between 7.0 and 7.4.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-Myostatin that is at least 2-fold, at least 10-fold, at least 50-fold, at least 100-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, or at least 10000-fold greater at a pH between 4.0 and 6.5 as compared to a pH between 7.0 and 7.4."
    },
    {
        "molecule_name": "antibodies, or antigen binding fragments thereof",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "10^−11",
        "unit": "M",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−3 </sup>M, 10<sup>−4 </sup>M, 10<sup>−5 </sup>M, 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M when the pH is between 4.0 and 6.5.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-myostatin ranging from 10<sup>−6 </sup>M, 10<sup>−7 </sup>M, 10<sup>−8 </sup>M, 10<sup>−9 </sup>M, 10<sup>−10 </sup>M, 10<sup>−11 </sup>M when the pH is between 7.0 and 7.4.\n* In some embodiments, the antibodies, or antigen binding fragments thereof, provided herein have a Kd of binding to pro/latent-Myostatin that is at least 2-fold, at least 10-fold, at least 50-fold, at least 100-fold, at least 500-fold, at least 1000-fold, at least 5000-fold, or at least 10000-fold greater at a pH between 4.0 and 6.5 as compared to a pH between 7.0 and 7.4."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "<10^−6",
        "unit": "M",
        "raw_mentions": "In another embodiment, an antibody, or an antigen-binding portion thereof, competes or cross-competes for binding to any of the antigens provided herein (e.g., pro/latent-myostatin) with an equilibrium dissociation constant, Kd, between the antibody and the protein of less than 10<sup>−6 </sup>M.\nIn other embodiments, an antibody, or an antigen-binding portion thereof, competes or cross-competes for binding to any of the antigens provided herein with a Kd in a range from 10<sup>−11 </sup>M to 10<sup>−6 </sup>M.\nIn another embodiment, an antibody, or an antigen-binding portion thereof, competes for binding to pro/latent-myostatin with an equilibrium dissociation constant, Kd, between the antibody, or antigen-binding portion thereof, and pro/latent-myostatin of less than 10<sup>−6 </sup>M.\nIn other embodiments, the antibody, or antigen-binding portion thereof, that competes with any of the antibodies, or antigen-binding portions thereof, provided herein binds to pro/latent-myostatin with a Kd in ranging from 10<sup>−11 </sup>M to 10<sup>−6 </sup>M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "<10^−6",
        "unit": "M",
        "raw_mentions": "In another embodiment, an antibody, or an antigen-binding portion thereof, competes or cross-competes for binding to any of the antigens provided herein (e.g., pro/latent-myostatin) with an equilibrium dissociation constant, Kd, between the antibody and the protein of less than 10<sup>−6 </sup>M.\nIn other embodiments, an antibody, or an antigen-binding portion thereof, competes or cross-competes for binding to any of the antigens provided herein with a Kd in a range from 10<sup>−11 </sup>M to 10<sup>−6 </sup>M.\nIn another embodiment, an antibody, or an antigen-binding portion thereof, competes for binding to pro/latent-myostatin with an equilibrium dissociation constant, Kd, between the antibody, or antigen-binding portion thereof, and pro/latent-myostatin of less than 10<sup>−6 </sup>M.\nIn other embodiments, the antibody, or antigen-binding portion thereof, that competes with any of the antibodies, or antigen-binding portions thereof, provided herein binds to pro/latent-myostatin with a Kd in ranging from 10<sup>−11 </sup>M to 10<sup>−6 </sup>M."
    },
    {
        "molecule_name": "antibody",
        "protein_target_name": "pro/latent-myostatin",
        "binding_metric": "Kd",
        "value": "10^−11 to 10^−6",
        "unit": "M",
        "raw_mentions": "In another embodiment, an antibody, or an antigen-binding portion thereof, competes or cross-competes for binding to any of the antigens provided herein (e.g., pro/latent-myostatin) with an equilibrium dissociation constant, Kd, between the antibody and the protein of less than 10<sup>−6 </sup>M.\nIn other embodiments, an antibody, or an antigen-binding portion thereof, competes or cross-competes for binding to any of the antigens provided herein with a Kd in a range from 10<sup>−11 </sup>M to 10<sup>−6 </sup>M.\nIn another embodiment, an antibody, or an antigen-binding portion thereof, competes for binding to pro/latent-myostatin with an equilibrium dissociation constant, Kd, between the antibody, or antigen-binding portion thereof, and pro/latent-myostatin of less than 10<sup>−6 </sup>M.\nIn other embodiments, the antibody, or antigen-binding portion thereof, that competes with any of the antibodies, or antigen-binding portions thereof, provided herein binds to pro/latent-myostatin with a Kd in ranging from 10<sup>−11 </sup>M to 10<sup>−6 </sup>M."
    }
]